Biopreservation companies focus on the development and provision of technologies and solutions for preserving biological materials, such as cells, tissues, and organs. These companies contribute to biobanking, regenerative medicine, and transplantation by offering cryopreservation and storage solutions that maintain the viability and functionality of biological specimens.
Latest Biopreservation Companies Updates:
Jan 2024
Azenta Acquired B Medical Systems, a leader in temperature-controlled storage and transportation solutions, expanding their biopreservation logistics capabilities.Launched a new biorepository facility in Singapore offering advanced cryopreservation and sample management services.
Thermo Fisher Scientific Introduced their latest line of cryogenic freezers featuring enhanced energy efficiency and temperature stability for optimal sample preservation.Developed novel biocompatible media formulations for specific cell types and applications, improving post-thawing cell viability and functionality.
BioStorage Technologies Partnered with a pharmaceutical company to provide biobanking and cell line management services for their clinical trials.Expanded their contract research organization (CRO) offerings to include biopreservation and sample management services for early-stage research projects.
Oxford Instruments Launched their next-generation vitrification system utilizing advanced cooling technology for improved stem cell cryopreservation outcomes.Collaborated with research institutions to develop new vitrification protocols for challenging cell types and tissues.
Aster Biosciences Received FDA approval for their cryopreservation device specifically designed for preserving patient-derived organoids for personalized medicine applications.Focused on developing biopreservation technologies for organs and complex tissues, expanding the potential applications of biobanking and regenerative medicine.
List of Biopreservation Key companies in the market
The Biopreservation market is expected to reach USD 6.01 Billion at a CAGR 11.5% during the forecast period 2023-2032. Biopreservation is a use of natural flora and its antibacterial products to preserve biological material. Biopreservation is playing an important role in healthcare and food industry to preserve the biological material or food product for a long time. The increasing expenditure on healthcare, growing demand for stem cell preservation and awareness about its use with regards to treatment of diseases are expected to drive the growth of the market. Moreover, increasing awareness about personalized medicines and its applications are contributing to the growth of the biopreservation market. According to the US Food and Drug Administration (FDA), The department has approved 16 personalized medicines in the year 2017, which accounts for 20% of total drug approvals.
The rising high price of biopreservation instruments and its maintenance, stability issues related to the specimen and lack of skilled personnel for handling the biopreservation process may hamper the growth of the market during the assessment period.
The biopreservation market has been segmented on the basis of product, biospecimen, and application.
On the basis of product, the market has been classified as media and equipment. The media subsegment has been further divided into nutrient media, sera, and growth factors and supplements. The equipment segment has been further divided into temperature control systems, accessories, alarms & monitoring systems, incubators, centrifuges, and other equipment. The temperature control systems segment has been further classified as freezers, cryogenic storage systems, thawing equipment, and refrigerators.
The biospecimen segment has been divided into human tissue samples, organs, stem cells, and other biospecimens.
The market, by source, has been segmented into regenerative medicine, biobanking, and drug discovery. On basis of regenerative medicine, the market has been divided into cell therapy, gene therapy, and others. Biobanking segment includes human egg, human sperm, and veterinary IVF.
The market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The biopreservation market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada.
The European market has been segmented into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.
The biopreservation market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The market in the Middle East & Africa has been segmented into the Middle East and Africa.
Regional Market Summary
Global Biopreservation Market Share, by Region, 2017 (%)
Source: MRFR Analysis
The Americas are likely to dominate the global biopreservation market owing to the adoption of advanced technology, increasing spending on healthcare R&D, the presence of a well-established healthcare system, and increasing in-house sample storage in hospitals and research institutes. Moreover, presence and recent merger and acquisition activities by market players in the region are contributing to the growth of the market. For instance, in 2017, Cesca Therapeutics Inc. has acquired Sacramento’s SynGen Inc. for USD 1 million with this acquisition company has managed to add cell separation and cord blood processing products in their portfolio.
The European market is expected to be the second-largest biopreservation market. The market growth in this region can be attributed to the increasing number of births and with-it continuous increase in demand for umbilical cord preservation. According to the European Commission, in the year 2016 more than 5.1 million babies were born in Europe. Moreover, a growing number of sperm and egg banks is contributing to the growth of the market in this region.
Asia-Pacific is expected to be the fastest-growing biopreservation market during the forecast period owing to the increasing population in the region, increasing awareness about stem cell preservation and continuous development in the healthcare sector due to government funding.
The market in the Middle East & Africa is expected to account for the smallest share of the global biopreservation market due to an underdeveloped healthcare sector, lack of technical knowledge, and poor medical facilities.
Key Players
Some of the key players in the global biopreservation market are:
Intended Audience
Biopreservation Market Highlights:
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)